(19)
(11) EP 1 742 914 A1

(12)

(43) Date of publication:
17.01.2007 Bulletin 2007/03

(21) Application number: 05723791.9

(22) Date of filing: 24.02.2005
(51) International Patent Classification (IPC): 
C07D 209/52(2006.01)
C07K 5/08(2006.01)
A61K 31/403(2006.01)
A61P 31/12(2006.01)
C07D 307/00(2006.01)
C07D 491/04(2006.01)
C07K 7/02(2006.01)
A61K 31/407(2006.01)
C07D 491/04(2006.01)
C07D 209/00(2006.01)
(86) International application number:
PCT/US2005/006083
(87) International publication number:
WO 2005/085197 (15.09.2005 Gazette 2005/37)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 27.02.2004 US 548423 P

(71) Applicant: SCHERING CORPORATION
Kenilworth, New Jersey 07033-0530 (US)

(72) Inventors:
  • BOGEN, Stephane, L.
    Somerset, New Jersey 08873 (US)
  • PAN, Weidong
    Somerset, New Jersey 08873 (US)
  • RUAN, Sumei
    Green Brook, New Jersey 08812 (US)
  • NJOROGE, F., George
    Warren, New Jersey 07059 (US)

(74) Representative: Adams, Harvey Vaughan John 
Mathys & Squire 120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)

   


(54) CYCLOBUTENEDIONE GROUPS-CONTAINING COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE